ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2022-04-26 咸鱼de爱

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：信号传导
经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈
从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。
Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022

39 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2023-05-31 匿名用户来自湖北省

偏重的研究方向：肿瘤;信号传导
经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。

40 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2023-06-29 ms6000002022277544 来自云南省

偏重的研究方向：信号传导
经验分享：大修修回一个月了，没有动静，是不是凉了

33 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2018-11-03 飞速的小鱼1657

审稿速度:1.0
经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历：
从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。

218 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2023-07-29 ms1000000583148994 来自四川省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：干细胞;细胞死亡
经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回
二审大约1个月小修语法问题返回后接受
总体来说速度比较正常第一次投稿运气不错

35 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2023-05-24 ms3000001728916488 来自云南省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：中药活性成分;机制研究
经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online

40 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2022-10-06 lovebanana

偏重的研究方向：肿瘤;机制研究;转移
经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高

39 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2022-01-27 916603706

投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待

57 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2023-05-18 ms7000001856452872 来自广东省

投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。

37 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1214427, encodeId=cbb8121442e8d, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：信号传导 经验分享：刚在本杂志中了人生第一篇文章，感谢论坛上前辈们的经验，特来回馈 从投稿到正式online经历了不到4个月的时间，一审两个月，两位审稿人，大修。因为是第一篇文章所以问题比较多，审稿人特别负责并且专业，一一给予指正，所幸不需要补实验。编辑给了两个月时间，一个月就修回了，然后再次外审，两周后接收，accepted后两天online。总算是没影响毕业，效率特别高，感谢审稿人和编辑，祝愿杂志越办越好。 Received 5 January 2022; Received in revised form 1 April 2022; Accepted 15 April 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=df9b5530548, createdName=咸鱼de爱, createdTime=Tue Apr 26 11:14:27 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2140012, encodeId=82af2140012c5, content=偏重的研究方向：肿瘤;信号传导 经验分享：Received: Mar 30,2023 Under review: April 10,2023 Substantial revision: May 08,2023 Revision received: May 14,2023 Under review: May 17, 2023 Accept: May 29, 2023 编辑和审稿人都很友好，一次非常好的投稿体验。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqPgiciaUpVUHLg98q2CZP8n9b8gJn9TJrvRIibb4r4UlV11qUo4EEeErPb0ibtBMBybCSlC9yGnwtRZw/132, createdBy=3d001973228, createdName=, createdTime=Wed May 31 00:41:39 CST 2023, time=2023-05-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2145366, encodeId=463b21453661e, content=偏重的研究方向：信号传导 经验分享：大修修回一个月了，没有动静，是不是凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81718320914, createdName=ms6000002022277544, createdTime=Thu Jun 29 07:41:09 CST 2023, time=2023-06-29, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=562717, encodeId=e17f562e171c, content=审稿速度:1.0 经验分享：刚在本刊发表论文一篇，跟大家分享一下投稿经历： 从投稿到online总共4个月，审稿很快，一审2周，major revision, 两个审稿人提的意见都很好，editor给了2个月时间返修，按照reviewers的意见补充实验，时间不太够，给editor写信请求多给半个月时间，editor非常nice,很快回信并且多给了三周。修回后2周accepted。accepted后第三天online。个人感觉是本很不错的杂志，而且效率很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=218, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/15/77a8c1d2821a8c0b27ee49351e1a16c2.jpg, createdBy=a0b92046938, createdName=飞速的小鱼1657, createdTime=Sat Nov 03 16:35:00 CST 2018, time=2018-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150380, encodeId=52eb215038029, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：干细胞;细胞死亡 经验分享：一审大约2个月意见比较友好，给了两个月的时间补完实验后返回 二审大约1个月小修语法问题返回后接受 总体来说速度比较正常第一次投稿运气不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c928222493, createdName=ms1000000583148994, createdTime=Sat Jul 29 16:10:40 CST 2023, time=2023-07-29, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2138735, encodeId=7dc02138e3539, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：中药活性成分;机制研究 经验分享：2023/1/1投稿 2023/1/2with editor 2023/1/11 under review 2023/2/27 majior revesion 2023/4/11返修回去 2023/4/20 minor revesion 2023/5/7 返修回去 2023/5/21接收 2023/5/24 online , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989b5400212, createdName=ms3000001728916488, createdTime=Wed May 24 07:54:00 CST 2023, time=2023-05-24, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2092018, encodeId=8e41209201804, content=偏重的研究方向：肿瘤;机制研究;转移 经验分享：22年尾声了，稿号才839，感觉没戏了，老期刊创新度要求高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/9883684c50eb4525aa0007900c15ab09/c44d99673a04497daa77b8386586df68.jpg, createdBy=70f62430863, createdName=lovebanana, createdTime=Thu Oct 06 09:28:11 CST 2022, time=2022-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188477, encodeId=d64f11884e715, content=投biomarkers被秒拒，转头了ABB外审了，希望有个好结果，期待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9b882996665, createdName=916603706, createdTime=Thu Jan 27 00:53:40 CST 2022, time=2022-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2137438, encodeId=9146213e43869, content=投稿之后under review 的日期已经变了两次了，有人遇到这种情况嘛，这是怎么回事呀，是不是凶多吉少。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75218516826, createdName=ms7000001856452872, createdTime=Thu May 18 12:16:24 CST 2023, time=2023-05-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2115978, encodeId=e38021159e801, content=这个杂志接收后多久要求付版面费？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=46ee1637472, createdName=silkwizard, createdTime=Wed Feb 22 20:25:22 CST 2023, time=2023-02-22, status=1, ipAttribution=河南省)]

2023-02-22 silkwizard 来自河南省

这个杂志接收后多久要求付版面费？

35 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务